Our D4 Global virtual event took place on 13th-16th October 2020. D4 Global was the world’s first truly global event […]
Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]
The UK Biobank Exome Sequencing Consortium has released, as preprint in medRxiv, early results from the exome sequencing data generated […]
Your weekly summary of recent genomics news and research! Top stories from the past week Stanford researchers have developed a […]
Nearly all of the body’s functions are based on cellular heterogeneity – from complex neurobiological functions, to the development of […]
In the past Genomics has faced a lot of controversy, particularly in relation to eugenics. Even today, applications of genomics, […]
The promise of single-cell gene expression data Genomic data are an excellent source of novel disease biomarkers and targets. In […]
Front Line Genomics is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on […]
The human body has 40 trillion cells and roughly 200 different cell types. Amongst the diverse cell types lies incredible […]
Monte Rosa Therapeutics is a spin-out formed by Versant Ventures, The Institute of Cancer Research (ICR) and Cancer Research UK […]
